Avanos Medical, Inc. (NYSE:AVNS) Reports Strong Q3 Earnings

Avanos Medical, Inc. (NYSE:AVNS) reported a significant earnings beat with an EPS of $0.22, surpassing estimates.The company's revenue reached $177.8 million, a 4.3% increase year-over-year, exceeding consensus estimates.Despite a challenging tariff environment, the Specialty Nutrition Systems segment saw double-digit growth, benefiting from strategic acquisitions.Avanos Medical, Inc. (NYSE:AVNS), a leader in the medical technology sector, focusing on innovative healthcare solutions, announced its third-qua ...